During Friday’s Current trade, Shares of Ameriprise Financial, Inc. (NYSE:AMP), gain 0.05% to $126.27.
Ameriprise Financial, Inc. (AMP) released the results of the new Retirement 2.0SM study, revealing that the majority of Gen Xers (76%) report proactively planning for their retirement, with eight in 10 (79%) respondents presently saving through a 401(k) plan, and seven in 10 (69%) investing in an IRA or similar account.
The Retirement 2.0 study, which surveyed more than 1,500 Americans between the ages of 35-50 with at least $100,000 in investable assets, took a comprehensive look at how Gen X is approaching retirement. The study also explored how they have invested and saved for this major milestone; and how they expect to spend their retirement years. Encouragingly, the study found that Gen Xers began planning for retirement early and started saving at the average age of 26. They anticipate relying on their 401(k) accounts (42%) or IRAs (29%) as their main sources of income during retirement, while pensions (14%) and Social Security (5%) are predictable to take a back seat as primary sources of retirement funding.
Ameriprise Financial, Inc., through its auxiliaries, provides various financial products and services to individual and institutional clients in the United States and internationally. The company’s Advice & Wealth Administration segment provides financial planning and advice, in addition to full-service brokerage services primarily to retail clients through its advisors. Its Asset Administration segment offers investment advice and investment products to retail, high net worth, and institutional clients through unassociated third party financial institutions and institutional sales force. This segment’s products comprise U.S. mutual funds and their non-U.S. equivalents, exchange-traded funds, variable product funds underlying insurance, and annuity separate accounts; and institutional asset administration products, such as traditional asset classes, separately managed accounts, individually managed accounts, collateralized loan obligations, hedge funds, collective funds, and property funds.
Shares of KBR, Inc. (NYSE:KBR), inclined 0.28% to $17.62, during its current trading session.
KBR and its wholly owned partner Granherne declared recently that they have signed a contract to form an alliance with Subsea 7 to deliver Concept and Front End Engineering and Design (FEED) services to the global offshore oil and gas industry.
The alliance is a co-operation agreement between the companies where Granherne will support Subsea 7 on concept and FEED studies and Subsea 7 will support Granherne with subsea engineering and technology. The alliance will operate on a global basis using the existing resources of these two market-leading companies.
KBR`s and Granherne`s expertise in field development planning, concept evaluation and FEED will complement Subsea 7`s subsea project administration and engineering experience and the application of technology and know-how to enable improved cost-benefit evaluation for clients. The alliance will be able to engage early with clients to provide them with the most cost-effective solutions during the important concept evaluation phase of a project.
KBR, Inc. operates as an engineering, construction, and services company worldwide. The company operates through three segments: Technology & Consulting, Engineering & Construction, and Government Services. The Technology & Consulting segment offers various services and solutions, counting licensing, engineering and design, proprietary equipment, plant automation, catalysts, and related consulting services to hydrocarbons, chemicals, and fertilizer markets.
Quest Diagnostics Inc (NYSE:DGX), during its Friday’s current trading session decreased -0.11% to $74.32.
Quest Diagnostics Incorporated (DGX), the world’s leading provider of diagnostic information services, declared recently that for the second quarter ended June 30, 2015, adjusted net income was $170 million contrast to $157 million for 2014. Adjusted diluted EPS not taking into account amortization was $1.25 in the second quarter of 2015, contrast to $1.19 in 2014. Amortization expense per diluted share was $0.08 in the second quarter of 2015 and $0.11 in 2014.
For the second quarter of 2015, stated net income was $118 million, or $0.81 per diluted share, contrast to $133 million, or $0.92 per diluted share, in 2014. Stated net income in the second quarter of 2015 was negatively influenced by charges of $52 million after tax, or $0.36 per diluted share, of which $41 million is associated with the company’s recent debt refinancing. The remainder of the charges were related to restructuring and integration costs and ongoing efforts to drive operational excellence. In the second quarter of 2014, stated net income was reduced by charges of $24 million after tax, or $0.16 per diluted share, primarily related to restructuring and integration costs associated with acquisitions and ongoing efforts to drive operational excellence.
Second quarter 2015 revenue of $1.93 billion grew by 1.2% as compared to the preceding year and grew 0.8% on an organic basis. Diagnostic information services revenue grew by 0.4%. Volume, measured by the number of requisitions, reduced by about 0.4%. Revenue per requisition grew by about 0.9%.
Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, in addition to related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; analytic, on-site prevention, and wellness services; and risk assessment services for the life insurance industry.
Finally, Splunk Inc (NASDAQ:SPLK), gained 1.22%, to $75.73.
Splunk Inc. (SPLK), provider of the leading software platform for real-time Operational Intelligence, recently declared it has attained Caspida, Inc., a leading innovator in machine learning and behavioral analytics. Under the terms of the agreement, Splunk has attained all of the outstanding stock of Caspida for an aggregate purchase price of about $190 million, counting about $127 million in cash and $63 million in restricted Splunk securities.
The combination of Splunk® and Caspida™ technology revolutionizes the security market by unifying world-class breach response with breach detection. Recent high-profile breaches show virtually all attacks happen with compromised credentials, and automated detection leveraging machine learning is the future for detecting known and unknown threats from insider and external attackers. Splunk customers now have out-of-the-box user behavioral analytics to assist detect, respond to and mitigate these threats. This combination of Splunk’s leading machine data platform with Caspida software provides the most comprehensive security analytics solution accessible recently.
Splunk, Inc. provides software products that enable organizations to gain real-time operational intelligence in the United States and internationally. The company’s products enable users to collect, index, search, explore, monitor, and analyze data regardless of format or source users. It offers Splunk Enterprise, a machine data engine with collection, indexing, search, reporting analysis, alerting, monitoring, and data administration capabilities; and Splunk Cloud service.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
